HomeProductsGeneral ReagentsChelates & Complexes(p-SCN-Bn)-dota
Chemical structure of CAS 127985-74-4

(p-SCN-Bn)-dota

In Stock•Starting at $108 for 5 mg•Purity ≥ 95%
CAS No.127985-74-4
MDL No.MFCD11112156
MFC24H33N5O8S
MW551.60
InChI KeyUDOPJKHABYSVIX-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg95%$108In Stock
10 mg95%$183In Stock
25 mg95%$309In Stock
50 mg95%$522In Stock
100 mg95%$886In Stock
250 mg95%$1503In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.127985-74-4
Product Name(p-SCN-Bn)-dota
Heavy Atom Count38Rotatable Bond Count11
Atom Stereo Count1Bond Stereo Count0
HBA10HBD4
TPSA174.520 ŲCharge0
Exact Mass551.20498Complexity1017.57
pKa3.413XLogP-0.108

Related Articles

Studies related to this compound and its mechanism of action

PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice.

PloS one • Vol. 2, Issue 9 • 2007
PMID: 17878942PMC: PMC1975469DOI: 10.1371/journal.pone.0000907

In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.

Nuclear medicine and biology • Vol. 34, Issue 3 • 2007
PMID: 17383579DOI: 10.1016/j.nucmedbio.2007.01.004

90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas.

Cancer immunology, immunotherapy : CII • Vol. 54, Issue 12 • 2005
PMID: 15926078PMC: PMC11034239DOI: 10.1007/s00262-005-0693-2

Targeted actinium-225 in vivo generators for therapy of ovarian cancer.

Cancer research • Vol. 63, Issue 16 • 2003
PMID: 12941838

Documentation

Similar Products